Falcão EMM, Trope BM, Godinho MM, Carneiro LH, de Araujo-Neto JM, Nogueira CAV, Ramos-E-Silva M. Cutaneous Eruption due to Telaprevir.
Case Rep Dermatol 2015;
7:253-62. [PMID:
26500538 PMCID:
PMC4612548 DOI:
10.1159/000439264]
[Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
Hepatitis C virus (HCV) chronically infects 0.5–3% of the world population. A large group of patients develop cirrhosis and its complications. Since 2011, telaprevir and boceprevir are used, improving the disease evolution. One of the main side effects of these drugs is skin eruption. We report a 53-year-old patient with cirrhosis due to HCV who started the classic treatment associated with telaprevir. In the ninth week, he presented a severe rash that required the interruption of this drug. We emphasize the importance of early recognition and appropriate management of adverse skin reaction.
Collapse